This inventor holds 1 USPTO granted patent. Top assignee: Taipei Medical University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Fan-Li Lin in Nanotechnology
Introduction
Fan-Li Lin is a prominent inventor based in Zhubei, Taiwan. He has made significant contributions to the field of nanotechnology, particularly in the development of nanoparticles for medical applications. His innovative work focuses on treating neovascularization and angiogenesis, which are critical issues in various eye conditions.
Latest Patents
Fan-Li Lin holds a patent for a self-assembled nanoparticle and its use for anti-angiogenesis. This patent, which includes a hyaluronic acid and a therapeutic peptide, provides a pharmaceutical composition aimed at treating or remitting neovascularization in eye segments. The method described in the patent involves inhibiting the formation or growth of blood vessels through the administration of the nanoparticle or pharmaceutical composition to a subject in need.
Career Highlights
Fan-Li Lin is affiliated with Taipei Medical University, where he continues to advance his research in nanotechnology and its applications in medicine. His work has garnered attention for its potential to improve treatment options for patients suffering from eye diseases related to abnormal blood vessel growth.
Collaborations
Some of his notable coworkers include Yu-Yi Wu and Ching-Li Tseng, who have collaborated with him on various research projects. Their combined expertise contributes to the innovative advancements in the field of nanomedicine.
Conclusion
Fan-Li Lin's contributions to nanotechnology, particularly in the development of therapeutic nanoparticles, highlight the importance of innovation in medical science. His work not only addresses critical health issues but also paves the way for future advancements in treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
